Table 1. Risk stratification of non-muscle-invasive bladder cancer 10, 11.
Risk category | EAU definition 9 | EAU recommendations | AUA definition 10 | AUA recommendations |
---|---|---|---|---|
Low | • Primary,
• Solitary (<3 cm), • Low-grade/G1, and • Ta |
• Single immediate post-TUR
instillation of chemotherapy |
• Solitary <3 cm,
• Low-grade, and • Ta |
• Single immediate post-TUR
instillation of chemotherapy |
Intermediate | • Any disease not fitting
low- or high-risk criteria |
• Single immediate post-TUR
instillation of chemotherapy, and either • Induction chemotherapy for 1 year, or • Induction BCG with 1 year of maintenance therapy |
• Low-grade Ta
recurrence <1 year • Solitary low-grade Ta >3 cm, • Multifocal low-grade Ta, • High-grade Ta ≤3 cm, or • Low-grade T1 |
• Single immediate post-TUR
instillation of chemotherapy, and either • Induction chemotherapy with or without maintenance, or • Induction BCG with maintenance |
High | • Any T1,
or
• High-grade/G3, or • CIS present, or • Multiple, recurrent, large (>3 cm), papillary (Ta), low-grade/G1 or G2 tumors |
• Single immediate post-TUR
instillation of chemotherapy, and either • Induction BCG with 1–3 years of maintenance therapy, or • Immediate radical cystectomy |
• High-grade T1
• Recurrent high-grade Ta • High-grade Ta >3 cm • CIS • Any high-grade failing BCG • Variant histology • LVI • High-grade prostatic urethral involvement |
• Induction BCG with
maintenance therapy, or • Immediate radical cystectomy for highest risk features (with LVI, variant histology, T1 with CIS, persistent T1 on re-TUR) |
AUA, American Urological Association; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; EAU, European Association of Urology; LVI, lymphovascular invasion; TUR, transurethral resection